Kobayashi Pharmaceutical Co., Ltd. (KBYPF)
39.47
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Kobayashi Pharmaceutical Total Assets (Quarterly) : 1.550B for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.550B |
| March 31, 2026 | 1.602B |
| December 31, 2025 | 1.757B |
| September 30, 2025 | 1.770B |
| June 30, 2025 | 1.805B |
| March 31, 2025 | 1.684B |
| December 31, 2024 | 1.689B |
| September 30, 2024 | 1.751B |
| June 30, 2024 | 1.630B |
| March 31, 2024 | 1.726B |
| December 31, 2023 | 1.897B |
| September 30, 2023 | 1.816B |
| June 30, 2023 | 1.844B |
| March 31, 2023 | 1.900B |
| December 31, 2022 | 1.939B |
| September 30, 2022 | 1.766B |
| June 30, 2022 | 1.846B |
| March 31, 2022 | 1.997B |
| December 31, 2021 | 2.193B |
| September 30, 2021 | 2.172B |
| June 30, 2021 | 2.157B |
| March 31, 2021 | 2.117B |
| December 31, 2020 | 2.309B |
| September 30, 2020 | 2.153B |
| June 30, 2020 | 2.085B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.055B |
| December 31, 2019 | 2.151B |
| September 30, 2019 | 2.060B |
| June 30, 2019 | 2.037B |
| March 31, 2019 | 1.992B |
| December 31, 2018 | 2.085B |
| September 30, 2018 | 1.979B |
| June 30, 2018 | 1.960B |
| March 31, 2018 | 1.981B |
| December 31, 2017 | 1.943B |
| September 30, 2017 | 1.824B |
| June 30, 2017 | 1.777B |
| March 31, 2017 | 1.762B |
| December 31, 2016 | 1.725B |
| September 30, 2016 | 1.919B |
| June 30, 2016 | 1.840B |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | 1.554B |
| December 31, 2014 | 1.486B |
| September 30, 2014 | 1.555B |
| June 30, 2014 | 1.640B |
| March 31, 2014 | 1.660B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Medifast, Inc. | 260.40M |
| Integrated BioPharma, Inc. | 25.34M |
| Kao Corp. | 11.68B |
| Shiseido Co., Ltd. | 7.838B |
| Skinvisible, Inc. | 0.1233M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 259.58M |
| Shareholders Equity (Quarterly) | 1.290B |
| Debt to Equity Ratio | 0.0034 |
| Current Ratio | 3.279 |
| Net Debt Paydown Yield | 0.01% |